Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Asleep at the Switch? Are We Failing to Recognize Obstructive Sleep Apnea in Patients with Atrial Fibrillation and Heart Failure?

Pollak PT, Povitz M.

Can J Cardiol. 2019 Nov;35(11):1426-1429. doi: 10.1016/j.cjca.2019.09.005. Epub 2019 Sep 20. No abstract available.

PMID:
31679613
2.

Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?

Pollak PT, Mitchell LB.

Can J Cardiol. 2019 Jun;35(6):694-698. doi: 10.1016/j.cjca.2019.04.009. Epub 2019 Apr 18. No abstract available.

PMID:
31151700
3.

Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel Syndrome.

Pollak PT, Sun GR, Kim RB.

Can J Cardiol. 2018 Mar;34(3):342.e17-342.e19. doi: 10.1016/j.cjca.2017.12.021. Epub 2017 Dec 27.

PMID:
29395704
4.
5.

Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.

Pollak PT, Spence JD.

N Engl J Med. 2016 Aug 25;375(8):801-2. doi: 10.1056/NEJMc1608041. No abstract available.

PMID:
27557315
6.

Herbal Cardiotoxicity: Can Mother Nature Hurt the Heart?

Pollak PT.

Can J Cardiol. 2016 Mar;32(3):291-3. doi: 10.1016/j.cjca.2015.08.024. Epub 2015 Nov 19. No abstract available.

PMID:
26604119
7.

Nondaily statin dosing: mechanisms of a potentially important approach to dealing with statin intolerance.

Pollak PT.

Can J Cardiol. 2013 Aug;29(8):895-8. doi: 10.1016/j.cjca.2013.03.013. No abstract available.

PMID:
23890473
8.

Falling between the cracks: a case of amiodarone toxicity.

Mackenzie C, Syed J, Pollak PT, Koren G.

CMAJ. 2011 Sep 6;183(12):1393-7. doi: 10.1503/cmaj.100351. Epub 2011 Jul 11. No abstract available.

9.

A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone.

Gabr RQ, Elsherbiny ME, Somayaji V, Pollak PT, Brocks DR.

Biomed Chromatogr. 2011 Oct;25(10):1124-31. doi: 10.1002/bmc.1581. Epub 2011 Feb 10.

PMID:
21308701
10.

Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics.

Pollak PT, Verjee ZH, Lyon AW.

J Clin Pharmacol. 2011 Jul;51(7):1112-5. doi: 10.1177/0091270010376973. Epub 2010 Jul 27. No abstract available.

PMID:
20663990
11.

Influence of peroxisome proliferator-activated receptor-alpha (PPARĪ±) activity on adverse effects associated with amiodarone exposure in mice.

Ernst MC, Sinal CJ, Pollak PT.

Pharmacol Res. 2010 Nov;62(5):408-15. doi: 10.1016/j.phrs.2010.07.004. Epub 2010 Jul 21.

PMID:
20654716
13.

How toxic is amiodarone to the liver?

Pollak PT.

J Gastrointestin Liver Dis. 2010 Mar;19(1):11-3. No abstract available.

14.

Amiodarone hepatotoxicity.

Babatin M, Lee SS, Pollak PT.

Curr Vasc Pharmacol. 2008 Jul;6(3):228-36. Review.

PMID:
18673162
15.

Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation.

Gillis AM, Burland L, Arnburg B, Kmet C, Pollak PT, Kavanagh K, Veenhuyzen G, Wyse DG.

Can J Cardiol. 2008 Mar;24(3):195-8.

16.

The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres.

Pollak PT, Wee V, Al-Hazmi A, Martin J, Zarnke KB.

Can J Cardiol. 2006 Mar 1;22(3):199-202.

17.

What is a doctor to do...with digoxin?

Pollak PT.

Can J Cardiol. 2005 Mar;21(3):287-8. No abstract available.

PMID:
15776119
18.

Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.

McCarthy TC, Pollak PT, Hanniman EA, Sinal CJ.

J Pharmacol Exp Ther. 2004 Dec;311(3):864-73. Epub 2004 Jul 20.

PMID:
15265979
19.

Use of population modeling to define rational monitoring of amiodarone hepatic effects.

Pollak PT, Shafer SL.

Clin Pharmacol Ther. 2004 Apr;75(4):342-51.

PMID:
15060512
20.
21.
22.

Monitoring of hepatic function during amiodarone therapy.

Pollak PT, You YD.

Am J Cardiol. 2003 Mar 1;91(5):613-6. No abstract available.

PMID:
12615276
23.
24.

Sertraline-induced hypoglycemia.

Pollak PT, Mukherjee SD, Fraser AD.

Ann Pharmacother. 2001 Nov;35(11):1371-4.

PMID:
11724085
25.

Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.

Yeung PK, Jamieson A, Smith GJ, Fice D, Pollak PT.

Int J Pharm. 2000 Aug 25;204(1-2):17-22.

PMID:
11011981
26.

Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions.

Pollak PT, Zbuk K.

Clin Pharmacol Ther. 2000 Jul;68(1):92-7.

PMID:
10945320
27.

Population pharmacokinetics of long-term oral amiodarone therapy.

Pollak PT, Bouillon T, Shafer SL.

Clin Pharmacol Ther. 2000 Jun;67(6):642-52.

PMID:
10872646
28.

Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations.

Pollak PT.

Am J Cardiol. 1999 Nov 4;84(9A):37R-45R. Review.

PMID:
10568658
29.

Pharmacokinetics and hemodynamic effects of diltiazem in healthy volunteers: comparing resting with the effect of exercise.

Yeung PK, Hung OR, Pollak PT, Klassen GA.

Int J Clin Pharmacol Ther. 1999 Aug;37(8):413-6.

PMID:
10475144
30.

Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodarone.

Pollak PT, Tan MH.

Am J Cardiol. 1999 Jan 15;83(2):296-300, A7.

PMID:
10073844
31.

Clinical efficacy of amiodarone.

Nolan PE Jr, Nappi J, Pollak PT.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):127S-137S. Review.

PMID:
9855345
32.

Oral amiodarone: historical overview and development.

Pollak PT.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):121S-126S. Review.

PMID:
9855344
33.

A simple high performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluid.

Yeung PK, Little R, Jiang Y, Buckley SJ, Pollak PT, Kapoor H, Veldhuyzen van Zanten SJ.

J Pharm Biomed Anal. 1998 Sep;17(8):1393-8.

PMID:
9800658
34.

Amrinone and amiodarone: serious confusion in the intravenous line.

Pollak PT, Pierce S, Cooke C.

Arch Intern Med. 1998 Jan 26;158(2):193-4. No abstract available.

PMID:
9448563
35.

Comment: ciprofloxacin-phenytoin interaction.

Pollak PT, Slayter KL.

Ann Pharmacother. 1997 Dec;31(12):1549-50. No abstract available.

PMID:
9416402
36.
37.

Effect of diltiazem on plasma concentrations of oxypurines and uric acid.

Yeung PK, Buckley SJ, Hung OR, Pollak PT, Barclay KD, Feng JD, Klassen GA.

Ther Drug Monit. 1997 Jun;19(3):286-91.

PMID:
9200769
38.

Effect of diltiazem on intraarterial blood pressure and heart rate during stress testing in patients with angina: a gender comparison study.

Klassen GA, Yeung PK, Barclay KD, Pollak PT, Hung OR, Buckley SJ.

J Clin Pharmacol. 1997 Apr;37(4):297-303.

PMID:
9115055
39.
41.
42.

Managed delay for coronary artery bypass graft surgery: the experience at one Canadian center.

Cox JL, Petrie JF, Pollak PT, Johnstone DE.

J Am Coll Cardiol. 1996 May;27(6):1365-73.

44.

Steady-state plasma concentrations of diltiazem and its metabolites in patients and healthy volunteers.

Yeung PK, Buckley SJ, Hung OR, Pollak PT, Barclay KD, Feng JD, Farmer PS, Klassen GA.

Ther Drug Monit. 1996 Feb;18(1):40-5.

PMID:
8848819
45.

Gender differences in exercise and recovery blood pressure responses in normal volunteers given diltiazem.

Klassen GA, Yeung PF, Barclay KD, Hung OR, Pollak PT, Buckley SJ.

J Clin Pharmacol. 1995 Dec;35(12):1144-9.

PMID:
8750364
46.

Delirium probably induced by clarithromycin in a patient receiving fluoxetine.

Pollak PT, Sketris IS, MacKenzie SL, Hewlett TJ.

Ann Pharmacother. 1995 May;29(5):486-8.

PMID:
7655131
47.
48.

Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect.

Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T.

J Infect Dis. 1994 Feb;169(2):434-7.

PMID:
8106778
49.

Erythrocyte adenosine transport. A rapid screening test for cardiovascular drugs.

Yeung PK, Mosher SJ, Li R, Farmer PS, Klassen GA, Pollak PT, McMullen M, Ferrier G.

J Pharmacol Toxicol Methods. 1993 Nov;30(3):163-7.

PMID:
8305718
50.

Myocardial metabolic and hemodynamic changes during propofol anesthesia for cardiac surgery in patients with reduced ventricular function.

Hall RI, Murphy JT, Landymore R, Pollak PT, Doak G, Murray M.

Anesth Analg. 1993 Oct;77(4):680-9.

PMID:
8214649

Supplemental Content

Loading ...
Support Center